Form 4: Solen Therapeutics CFO James H. Mackaness Sells Shares to Cover Tax Obligations

James H. Mackaness, CFO of Soleno Therapeutics Inc., sold shares of common stock on April 1, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• On April 1, 2024, James H. Mackaness, the CFO of Soleno Therapeutics Inc., executed two transactions involving the sale of common stock.
• The first transaction involved the sale of 3,104 shares at a weighted average price of $41.1227, with individual prices ranging from $40.42 to $41.415.
• The second transaction involved the sale of 2,071 shares at a weighted average price of $41.6671, with individual prices ranging from $41.42 to $42.28.
• These sales were conducted to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
• Following these transactions, Mackaness directly owns 62,953 shares of Soleno Therapeutics Inc.
• Certain of these securities are RSUs, each representing a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to insider trading. It doesn't inherently convey positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are a routine part of the US stock market, and are required by the SEC to ensure transparency when company insiders trade their own company's stock. It is not necessarily indicative of the company's performance or future prospects.

Key Dates